stoxline Quote Chart Rank Option Currency Glossary
  
(NNVC)
  0 (0%)    09-27 09:28
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-09-26 4:50:04 PM
Short term     
Mid term     
Targets 6-month :  1.71 1-year :  1.79
Resists First :  1.46 Second :  1.53
Pivot price 1.43
Supports First :  1.35 Second :  1.12
MAs MA(5) :  1.42 MA(20) :  1.43
MA(100) :  1.47 MA(250) :  1.39
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  38.7 D(3) :  47.3
RSI RSI(14): 45.8
52-week High :  1.91 Low :  0.93
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ NNVC ] has closed above bottom band by 24.6%. Bollinger Bands are 76.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.42 - 1.43 1.43 - 1.44
Low: 1.38 - 1.39 1.39 - 1.4
Close: 1.4 - 1.42 1.42 - 1.44
Company Description

Headline News

Sat, 20 Sep 2025
Block Trades: Is NNVC stock a good dividend stock - 2025 Trading Recap & Real-Time Stock Entry Alerts - خودرو بانک

Fri, 19 Sep 2025
Aug Closing: Why is NNVC stock going down - Dollar Strength & Entry Point Confirmation Signals - خودرو بانک

Tue, 09 Sep 2025
NanoViricides to present at Life Science Executive Partnering Congress in Boston - Proactive financial news

Wed, 27 Aug 2025
NanoViricides says broad-spectrum antiviral candidate NV-387 could address current, emerging and future COVID strains - Proactive financial news

Wed, 16 Jul 2025
NanoViricides says MPox drug candidate NV-387 poised for Phase II trial as WHO extends global health emergency - Proactive financial news

Wed, 16 Jul 2025
NanoViricides Targets Multi-Billion MPox Market with Superior Treatment as WHO Extends Global Emergency - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 12 (M)
Shares Float 11 (M)
Held by Insiders 4.5 (%)
Held by Institutions 11.3 (%)
Shares Short 473 (K)
Shares Short P.Month 348 (K)
Stock Financials
EPS -0.82
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.89
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -40.8 %
Return on Equity (ttm) -65.9 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.77
Qtrly Earnings Growth 0 %
Operating Cash Flow -6 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -1.74
PEG Ratio 0
Price to Book value 1.57
Price to Sales 0
Price to Cash Flow -2.65
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android